Kestra Private Wealth Services LLC lowered its position in Veru Inc. (NASDAQ:VERU – Get Rating) by 0.6% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 315,826 shares of the company’s stock after selling 1,942 shares during the period. Kestra Private Wealth Services LLC owned about 0.39% of Veru worth $1,525,000 as of its most recent SEC filing.
Other large investors have also made changes to their positions in the company. ProShare Advisors LLC bought a new position in Veru during the 4th quarter worth about $82,000. BNP Paribas Arbitrage SA increased its holdings in Veru by 28.1% during the 4th quarter. BNP Paribas Arbitrage SA now owns 17,830 shares of the company’s stock worth $105,000 after purchasing an additional 3,913 shares in the last quarter. Teacher Retirement System of Texas increased its holdings in Veru by 22.4% during the 4th quarter. Teacher Retirement System of Texas now owns 12,360 shares of the company’s stock worth $73,000 after purchasing an additional 2,258 shares in the last quarter. Qube Research & Technologies Ltd bought a new position in Veru during the 4th quarter worth about $73,000. Finally, Blair William & Co. IL increased its holdings in Veru by 1.6% during the 4th quarter. Blair William & Co. IL now owns 314,925 shares of the company’s stock worth $1,855,000 after purchasing an additional 5,050 shares in the last quarter. Institutional investors own 60.55% of the company’s stock.
Insider Activity at Veru
In related news, Director Mario Eisenberger sold 100,000 shares of the firm’s stock in a transaction dated Monday, August 15th. The shares were sold at an average price of $20.04, for a total value of $2,004,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 23.10% of the stock is currently owned by company insiders.
Analysts Set New Price Targets
Veru Price Performance
Shares of NASDAQ VERU opened at $14.28 on Friday. Veru Inc. has a fifty-two week low of $4.34 and a fifty-two week high of $24.55. The stock has a market capitalization of $1.14 billion, a price-to-earnings ratio of -24.20 and a beta of -0.44. The business has a 50-day moving average of $15.29 and a 200-day moving average of $11.92.
Veru Inc, an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N.
- Get a free copy of the StockNews.com research report on Veru (VERU)
- 3 Banks Worth Considering For Q4
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- MarketBeat: Week in Review 9/12 – 9/16
- No One Told These 3 Stocks It’s a Down Week
- Is There a Cure for What is Ailing Teladoc Stock?
Receive News & Ratings for Veru Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veru and related companies with MarketBeat.com's FREE daily email newsletter.